Close
Nordic 9Nordic 9

Technikos (investor - Others)

United Kingdom
See something wrong or missing? Let us know
Offices:London

Technikos is a specialist medical technology fund established to support the commercialisation of the University of Oxford's Institute of Biomedical Engineering (IBME) spinouts. 

Average round investment:142M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: United Kingdom OrganOx
Mostly invests in: United Kingdom United Kingdom (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Technikos

Name Criteria
Spain Escala Capital
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Ridgeback Capital Management
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Monashee Investment Management
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Czech Republic PPF Group
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan Terumo Corporation
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Avidity Partners
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Access Biotechnology
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Singapore Lyfe Capital
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China Lilly Asia Ventures
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States BrightEdge Fund
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top